health care for
We are building a better future for nearly 350 million people worldwide by enabling early, accurate and affordable diagnosis of genetic disorders.
We apply rigorous science and do tireless research to develop medical technology solutions that will help patients live longer and better.
Our products and services accelerate the diagnosis journey and advance inclusion, diversity and equity in care and treatment.
04 Jan 2023gMendel® wins €500k grant from the EUROSTARS funding programme to develop a novel non-invasive prenatal screening tool for detection of genetic disorders powered by AI.
22 Dec 2022The Year in Review. As 2022 draws to a close, explore gMendel’s round-up of activities that dominated the year.
15 Nov 2022gMendel® announced today its first Board of Directors and appointments of Lars Staal Wegner, Chairman, and Hanna Pyokari, Member, effective November 1st, 2022.
27 Sep 2022gMendel® moves into an investment agreement with Polish biotech company genXone for further cooperation in diagnosis of genetic disorders.
A genetic disorder is a disease caused in whole or in part by a change in the DNA sequence away from the normal sequence.
Genetic disorders can be caused by a mutation in one gene, by mutations in multiple genes, by a combination of gene mutations and environmental factors, or by damage to chromosomes, the structures that carry genes.